Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:KURO
- CUSIP: N/A
- Web: N/A
- Market Cap: $174.1 million
- Outstanding Shares: 14,508,000
- 50 Day Moving Avg: $12.00
- 200 Day Moving Avg: $12.00
- 52 Week Range: $12.00 - $12.00
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.80
- P/E Growth: 0.00
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: $4.08 per share
- Price / Book: 2.94
Frequently Asked Questions for Kura Oncology (NASDAQ:KURO)
What is Kura Oncology's stock symbol?
Kura Oncology trades on the NASDAQ under the ticker symbol "KURO."
Who are some of Kura Oncology's key competitors?
Some companies that are related to Kura Oncology include Sonus Networks (SONS), RadNet (RDNT), Primo Water (PRMW), Old Second Bancorp (OSBC), Hudson Technologies (HDSN), GlycoMimetics (GLYC), Synutra International (SYUT), CNB Financial Corp (CCNE), Bancorp (TBBK), United Insurance Holdings Corp (UIHC), Corbus Pharmaceuticals Holdings (CRBP), Accuray Incorporated (ARAY), Comtech Telecomm. Corp. (CMTL), ChemoCentryx (CCXI), Titan Machinery (TITN), Artesian Resources (ARTNA), Limelight Networks (LLNW) and Seadrill Partners LLC (SDLP).
How do I buy Kura Oncology stock?
Shares of Kura Oncology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Kura Oncology stock cost?
One share of Kura Oncology stock can currently be purchased for approximately $12.00.
Consensus Ratings for Kura Oncology (NASDAQ:KURO) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Kura Oncology (NASDAQ:KURO)
(Data available from 5/24/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|12/30/2015||Oppenheimer Holdings Inc.||Initiated Coverage||Outperform||N/A|
|9/17/2015||Leerink Swann||Initiated Coverage||Outperform||N/A|
Earnings History for Kura Oncology (NASDAQ:KURO)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Kura Oncology (NASDAQ:KURO)
Current Year EPS Consensus Estimate: $-2.58 EPS
Next Year EPS Consensus Estimate: $-2.50 EPS
Dividend History for Kura Oncology (NASDAQ:KURO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Kura Oncology (NASDAQ:KURO)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Kura Oncology (NASDAQ:KURO)
Latest Headlines for Kura Oncology (NASDAQ:KURO)
Kura Oncology (KURO) Chart for Wednesday, May, 24, 2017